Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon L Walmsley

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
HIV/AIDS (Auckland, N.Z.)|April 21, 2017
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeksKathleen E Squires, Benjamin Young, Lizette Santiago, et al.
Placenta|December 14, 2020
Exploring the impact of HIV infection and antiretroviral therapy on placenta morphologyMichael Yampolsky, Oleksandr Shlakhter, Dianna Deng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2002
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodiesStephen D Shafran, Brian Conway, Errol Prasad, et al.
The Journal of Infectious Diseases|June 25, 2004
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patientsMartin S King, Barry M Bernstein, Sharon L Walmsley, et al.
AIDS (London, England)|April 24, 2018
Medication nonadherence, multitablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppressionCelline C Almeida-Brasil, Erica E M Moodie, Taylor McLinden, et al.
Lancet (London, England)|August 8, 2006
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trialsCharles B Hicks, Pedro Cahn, David A Cooper, et al.
Drug and Alcohol Dependence|March 16, 2018
Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysisTaylor McLinden, Erica E M Moodie, Anne-Marie Hamelin, et al.
The Journal of Infectious Diseases|January 8, 2016
Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral TherapyEszter Papp, Kayode Balogun, Nicole Banko, et al.
Frontiers in Nutrition|December 9, 2021
The Dietary Inflammatory Index Is Not Associated With Gut Permeability or Biomarkers of Systemic Inflammation in HIV Immunologic Non-respondersFat Malazogu, Rodney K Rousseau, Nitin Shivappa, et al.
AIDS and Behavior|February 26, 2016
Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbiditiesJoseph Cox, Anne-Marie Hamelin, Taylor McLinden, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
HIV/AIDS (Auckland, N.Z.)|April 21, 2017
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeksKathleen E Squires, Benjamin Young, Lizette Santiago, et al.
Placenta|December 14, 2020
Exploring the impact of HIV infection and antiretroviral therapy on placenta morphologyMichael Yampolsky, Oleksandr Shlakhter, Dianna Deng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2002
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodiesStephen D Shafran, Brian Conway, Errol Prasad, et al.
The Journal of Infectious Diseases|June 25, 2004
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patientsMartin S King, Barry M Bernstein, Sharon L Walmsley, et al.
AIDS (London, England)|April 24, 2018
Medication nonadherence, multitablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppressionCelline C Almeida-Brasil, Erica E M Moodie, Taylor McLinden, et al.
Lancet (London, England)|August 8, 2006
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trialsCharles B Hicks, Pedro Cahn, David A Cooper, et al.
Drug and Alcohol Dependence|March 16, 2018
Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysisTaylor McLinden, Erica E M Moodie, Anne-Marie Hamelin, et al.
The Journal of Infectious Diseases|January 8, 2016
Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral TherapyEszter Papp, Kayode Balogun, Nicole Banko, et al.
Frontiers in Nutrition|December 9, 2021
The Dietary Inflammatory Index Is Not Associated With Gut Permeability or Biomarkers of Systemic Inflammation in HIV Immunologic Non-respondersFat Malazogu, Rodney K Rousseau, Nitin Shivappa, et al.
AIDS and Behavior|February 26, 2016
Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbiditiesJoseph Cox, Anne-Marie Hamelin, Taylor McLinden, et al.
Pageof 11